T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.06B |
| 2 |
Amphenol
APH
|
+$728M |
| 3 |
Advanced Micro Devices
AMD
|
+$608M |
| 4 |
Zscaler
ZS
|
+$517M |
| 5 |
Northrop Grumman
NOC
|
+$479M |
Top Sells
| 1 |
UnitedHealth
UNH
|
+$1B |
| 2 |
Mastercard
MA
|
+$809M |
| 3 |
Visa
V
|
+$621M |
| 4 |
Fortinet
FTNT
|
+$606M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$568M |
Sector Composition
| 1 | Technology | 27.6% |
| 2 | Healthcare | 20.51% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 11.2% |
| 5 | Financials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
McGrath RentCorp
MGRC
$3.02B
| $116M | 0.08% |
1,038,460
+120,829
| +13% | +$13.5M |
|
|
BPMC
252
DELISTED
Blueprint Medicines
BPMC
| $115M | 0.08% |
1,302,810
+605,783
| +87% | +$53.6M |
|
253
Aon
AON
$79B
| $114M | 0.08% |
+284,411
| New | +$114M |
|
254
Loar Holdings
LOAR
$7.35B
| $113M | 0.07% |
1,601,485
+1,119,958
| +233% | +$79.1M |
|
255
Doximity
DOCS
$13B
| $113M | 0.07% |
1,946,221
-1,129,520
| -37% | -$65.5M |
|
256
Warrior Met Coal
HCC
$3.06B
| $113M | 0.07% |
2,361,627
+367,326
| +18% | +$17.5M |
|
257
Insmed
INSM
$31.1B
| $113M | 0.07% |
1,476,948
-505,759
| -26% | -$38.6M |
|
258
Permian Resources
PR
$9.66B
| $111M | 0.07% |
7,979,881
-384,771
| -5% | -$5.33M |
|
259
PBF Energy
PBF
$3.47B
| $109M | 0.07% |
5,728,843
+3,612,447
| +171% | +$69M |
|
260
Arcellx
ACLX
$4B
| $109M | 0.07% |
1,665,138
+959,216
| +136% | +$62.9M |
|
261
Highwoods Properties
HIW
$3.44B
| $109M | 0.07% |
3,660,872
+10,331
| +0.3% | +$306K |
|
262
H.B. Fuller
FUL
$3.3B
| $107M | 0.07% |
1,911,352
+141,577
| +8% | +$7.95M |
|
263
FTAI Aviation
FTAI
$17B
| $107M | 0.07% |
964,529
+225,920
| +31% | +$25.1M |
|
264
Royal Gold
RGLD
$12.2B
| $107M | 0.07% |
654,466
-139,313
| -18% | -$22.8M |
|
|
NTST
265
NETSTREIT Corp
NTST
$1.75B
| $107M | 0.07% |
6,721,968
-112,150
| -2% | -$1.78M |
|
266
ESCO Technologies
ESE
$5.19B
| $106M | 0.07% |
666,535
-126,197
| -16% | -$20.1M |
|
267
Macerich
MAC
$4.57B
| $105M | 0.07% |
6,130,323
+1,754,466
| +40% | +$30.1M |
|
268
Cardinal Health
CAH
$36B
| $105M | 0.07% |
+761,781
| New | +$105M |
|
269
BrightSpring Health Services
BTSG
$4.65B
| $104M | 0.07% |
5,772,772
+4,189,805
| +265% | +$75.8M |
|
270
TPG
TPG
$8.7B
| $104M | 0.07% |
2,201,727
+481,418
| +28% | +$22.8M |
|
271
Walker & Dunlop
WD
$2.9B
| $104M | 0.07% |
1,218,881
+21,310
| +2% | +$1.82M |
|
272
West Pharmaceutical
WST
$18.1B
| $103M | 0.07% |
462,073
-271,189
| -37% | -$60.7M |
|
273
StepStone Group
STEP
$4.79B
| $103M | 0.07% |
1,975,494
+73,128
| +4% | +$3.82M |
|
274
Madison Square Garden
MSGS
$4.96B
| $103M | 0.07% |
528,545
+29,938
| +6% | +$5.83M |
|
275
Johnson & Johnson
JNJ
$426B
| $102M | 0.07% |
+617,824
| New | +$102M |
|